The annual Community Oncology Conference continues to be developed by community oncology providers, administrators, staff, and patients to address their needs in the real world.
At this years 2023 conference we will have 50+ speakers and co-chairs touching on subjects like Practice Perspectives on the Enhancing Oncology Model, Federal and state policies to curb PBM bad behavior, Integrative medicine in cancer and much more.
Our Dynamic Keynote Speaker
Our Dynamic Keynote Speaker
Will Flanary, MD, aka “Dr. Glaucomflecken”
THURSDAY, MARCH 23, 2023 AT 9:40 AM EDT
Will Flanary is an ophthalmologist and part time comedian who moonlights in his free time as “Dr. Glaucomflecken,” a social media personality who creates medical-themed comedy shorts to an audience of over 3 million across social media. His humor has been shaped by the tribulations of med school and residency, but also by his experiences as a patient.
Will is a 2-time testicular cancer survivor as well as a survivor of cardiac arrest, saved by his intrepid wife and her timely CPR. Initially used as a creative outlet to cope with these health challenges, Will’s comedy has evolved over time to incorporate biting satire of the US health care system, academic publishing, and interpersonal conflicts pervasive in the medical system. He is a frequent keynote speaker who encourages medical audiences to embrace humor in everyday life.
Conference Speakers
Judith Alberto, MHA, RPh, BCOP
Community Oncology Alliance
Judith Alberto, MHA, RPh, BCOP
Thursday, March 23rd; 11:00 – 11:45 AM
Practice Perspectives: The Enhancing Oncology Model & Commercial Payment Reform Initiatives, Moderator
About the Speaker
Judy Alberto, MHA, RPh, BCOP is Director of Clinical Initiatives at the Community Oncology Alliance (COA), the nation’s only non-profit organization dedicated to preserving and protecting local, affordable, and accessible cancer care. In this role, she supports and promotes the success of community oncology practices participating in clinical and payment reform initiatives.
Working closely with COA’s quality and value team, Alberto seeks to support the design, awareness, and participation in oncology payment and delivery reform initiatives. This includes oncology models from the Centers for Medicare & Medicaid Services, as well as participants in the National Cancer Treatment Alliance, a COA-led clinically integrated network engaging directly with employers and payers. Alberto also helps lead the Community Oncology Pharmacy Association (COPA), an 875+ strong peer-to-peer network of medically integrated pharmacies located in independent community oncology and urology practices across the country.
Prior to joining COA, Judy was the director of oncology and investigational drug services pharmacy at the Sidney Kimmel Cancer Center – Jefferson Health. She joined Jefferson in 2010, working her way up from patient care pharmacist to her directorship. Prior to joining Jefferson, she worked as a pharmacist at Express Scripts in Bensalem, PA, and the University of Pennsylvania Health System.
Judy received her pharmacy degree from the Philadelphia College of Pharmacy and Science and a Master of Healthcare Administration from the University of Arizona.
Miriam Atkins, MD, FACP
AO Multispecialty Clinic, Community Oncology Alliance
Miriam Atkins, MD, FACP
Thursday, March 23rd; 8:00 – 8:45 AM
20 Years of COA: The Value of Community Oncology
About the Speaker
Dr. Atkins earned a Bachelor of Arts in Biology from Hampton University, Hampton, VA and her Doctor of Medicine from Eastern Virginia Medical School, Norfolk, VA. She completed her Residency in Internal Medicine (1993) and her Fellowship in Hematology/Oncology (1996) at Brooke Army Medical Center, Fort Sam Houston, San Antonio, TX. While serving in the Army, she attained the rank of Major. Dr. Atkins worked at Texas Oncology for two years prior to moving to Augusta, GA. She joined, Augusta Oncology, the only privately-owned Oncology practice in the Augusta, GA area in 2000. She is board certified in Medical Oncology.
Dr. Atkins is the Associate Medical Director for Pruitt Hospice, Assistant Clinical Professor for the American University of Antigua and the University of Medicine and Health Sciences in St. Kitts. She holds leadership positions at the hospitals in Augusta, GA. Dr. Atkins is the Vice President of the Medical Executive Committee at University Hospital and the former chairperson of the Credentials Committee for University HealthLink. She is a member of the Cancer Committee at Doctors Hospital and University Hospital.
Dr. Atkins has been an active member of the Community Oncology Alliance since its inception. She is currently the CPAN Medical Co-chair and the Secretary of the organization.
In her spare time, Dr. Atkins enjoys traveling and competitive Ballroom Dancing.
Robert Baird, Jr., RN, MSA
National Cancer Treatment Alliance
Robert Baird, Jr., RN, MSA
Thursday, March 23rd; 9:05 – 9:55 AM
The New Horizon: Working Directly with Employers, Moderator
About the Speaker
Robert has extensive experience in healthcare management developing strategic plans and directing financial, operational and clinical initiatives. He is currently the President of the National Cancer Treatment Alliance (NCTA) positioning community oncology practices for success across the Nation in the changing health care environment. Prior to joining NCTA Robert was the CEO of Dayton Physicians, where he merged 3 independent Physician practices (Medical Oncology/Radiation Oncology/Urology) to create a large multi-specialty practice. He expanded the network from 2 locations to 6 comprehensive centers, 18 to over 40 Providers and generated over $170 million in annual revenues. Robert received his Master of Science in Hospital and Health Service Administration from Central Michigan University, a Bachelor of Science in Education from Bowling Green State University and a Nursing Degree from Excelsior College.
Glenn Balasky
Rocky Mountain Cancer Centers
Glenn Balasky
Thursday, March 23rd; 2:25 – 3:20 PM
Survive & Prosper: Optimizing Revenue & Increasing Efficiency in Your Practice
About the Speaker
In May of 2014, Glenn Balasky joined Rocky Mountain Cancer Centers (RMCC) as the Executive Director for this progressive 55 physician multi-specialty oncology group. He has over 21 years of experience in oncology practice operations and management and has been involved in healthcare for his entire career.
Prior to joining RMCC his most recent positions included a Director of Marketing position at Cardinal Health and 10 years as Executive Director at The Zangmeister Center in Columbus, OH. There he helped another leading oncology group build a stand-alone cancer center putting a broad variety of cancer services under one roof for the first time in central Ohio.
Glenn has experience in several areas of oncology practice management including electronic medical records, pharmacy, and practice operations. He has made presentations at several national meetings on the business of oncology and has been to Washington D.C. numerous times to work with congressional representatives on cancer related issues.
Glenn is like all of us and has seen family members and friends pass away due to cancer. His commitment to making cancer care better at RMCC comes through his ability to identify complex problems and find solutions to solve the problems. He believes that everyone is an important part of the team at RMCC and has an equally important role in helping patients through their healthcare journey.
He is a graduate of the University of Michigan with a bachelor’s degree in Microbiology. Outside of work he enjoys running, cycling, and skiing and is very proud of the accomplishments of his wife and his two adult children.
Sibel Blau, MD
Northwest Medical Specialties, Quality Cancer Care Alliance Network
Sibel Blau, MD
Thursday, March 23rd; 4:40 – 5:25 PM
Thinking Outside the Box: Going Beyond the “Traditional” Model of the Community Oncology Practice
About the Speaker
Dr. Sibel Blau is a Hematologist and Oncologist with special interest and expertise in breast cancer, multiple myeloma and stem cell transplant.
She is the Medical Director at Northwest Medical Specialties, PLLC, where she also runs the clinical research and Precision Medicine program.
She is one of the founding members and the President/CEO of the Quality Cancer Care Alliance Network (QCCA) that is a national organization with a focus of value-based care, education, and research as well as Exigent Research, an innovative research network of independent practices throughout the US to provide high quality, accelerated and accessible research to the communities where patients are treated. She is a board member and past President of Washington State Medical Oncology Society (WSMOS). She is involved in multiple committees at national organizations like ASCO, COA, ACCC.
She is also a member of All4cure, which is a transparent platform for discussion between experts in myeloma, researchers, scientists and patients.
She is the founder and president of the Journey Fund which is a community-based, not-for-profit organization committed to cancer patients facing barriers that affect their treatment with donations and community resources that make it possible for us to assist cancer patients facing social, financial, or emotional obstacles, toward a courageous journey, with dignity.
Ed Bryson
Texas Oncology
Ed Bryson
Thursday, March 23rd; 1:35 – 2:20 PM
Marketing & Advocacy: Practical Applications of Traditional & Social Media to Elevate Your Practice
About the Speaker
Ed is an experienced communications strategist and counselor, and a former award-winning broadcast journalist. He joined Texas Oncology in 2018, after serving for seven years on the public relations agency team at FleishmanHillard supporting the practice. He leads internal and external communications, including media relations, social media, and an integrated content program that includes an online news hub, a monthly email newsletter, and a soon-to-be-launched print magazine. Ed is a fan of live music and craft beer, and fortunately lives in Austin, Texas where both are plentiful.
Moshe C. Chasky, MD, FACP
Alliance Cancer Specialists
Moshe C. Chasky, MD, FACP
Thursday, March 23rd; 8:50 – 9:35 AM
The Hospital Conundrum: A Gameplan for Fending Off Attacks & Coexisting
About the Speaker
Dr. Chasky is a physician specializing in Hematology and Medical Oncology. He is a partner at the largest community oncology practice in the greater Philadelphia area and serves on the Board of Directors. He completed a fellowship at Fox Chase Cancer Center in 2008. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Chasky is the Chair of the Clinical Practice Committee at the American Society of Clinical Oncology and the current president of the Pennsylvania Society of Oncology and Hematology. He serves on the Board of Directors of Community Oncology Alliance. Previously, Dr. Chasky served as president of Lower Merion Synagogue in his community from 2020 through 2022.
Christian G. Downs, JD, MHA
Association of Community Cancer Centers
Christian G. Downs, JD, MHA
Friday, March 24th; 8:05 – 9:05 AM
Legislative Updates From Capitol Hill
About the Speaker
Christian G. Downs, JD, MHA, is the Executive Director of the Association of Community Cancer Centers (ACCC). In this capacity, he works with the ACCC Board and leadership on issues that affect providers and the delivery of quality cancer care in physician practices, hospital cancer programs, freestanding cancer centers, health systems, and other oncology care settings. In addition, he helps to further ACCC’s mission through coalition building with other oncology stakeholder organizations to ensure continued patient access to care.
ACCC is a multidisciplinary cancer organization representing more than 2,500 community-based cancer programs. The 24,000-plus membership includes physicians, nurses, pharmacists, social workers, cancer program and practice administrators, patient navigators, financial advocates, coders and billers, and many other disciplines.
ACCC’s core purposes are advocacy and education. Over the past several years, ACCC has launched major education initiatives in areas such as cancer survivorship, patient navigation, molecular testing, immunotherapy, oral chemotherapy, adherence, chemotherapy scheduling strategies, financial advocacy, and the use of clinical practice guidelines. ACCC initiatives are tailored to the unique needs of community-based cancer care professionals and offer specific strategies and processes to help members implement change and performance improvement in their programs.
David Eagle, MD
New York Cancer & Blood Specialists
David Eagle, MD
Thursday, March 23rd; 3:50 – 4:45 PM
Updates & Solutions: State & Federal Policies Aimed at Curbing PBM Bad Behavior, Moderator
About the Speaker
Dr. Eagle graduated from the University of Virginia School of Medicine in 1993. He then completed internal medicine residency and hematology oncology fellowship at the University of Florida.
Dr. Eagle began private practice oncology in the Lake Norman region of North Carolina in 2000. He then joined New York Cancer & Blood Specialists in 2021 serving as Chair of Legislative Affairs and Patient Advocacy.
Dr. Eagle is a former President of the Community Oncology Alliance and currently Chairs the COA Nominating Committee. He formerly managed the Practice and Policy section for the journal Oncology. Dr. Eagle has served as the Oncology Representative to the Carrier Advisory Committee in the state of North Carolina. Dr. Eagle has published numerous articles on oncology health care policy and cost of care. He has participated in two Capitol Hill briefings for oncology health policy. Dr. Eagle has twice served as an invited guest to The Oncology Show on the Doctors Radio Channel on Sirius XM.
Jason Ervin
Oklahoma Cancer Specialists & Research Institute
Jason Ervin
Friday, March 24th; 12:55 – 1:45 PM
Securing Your Practice: Dealing With Cyberattacks & Other Disasters
About the Speaker
Jason Ervin is the Director of the Oncology Service Line for the Oklahoma Cancer Specialists and Research Institute (OCSRI) and Ascension St. John Medical Center in Tulsa, Oklahoma. In this role, Jason is responsible for seamless integration of oncology services throughout the continuum of care, including leadership of American College of Surgeons COC quality initiatives. In addition to overseeing the Oncology Service Line, Jason is responsible for the management and leadership of OCSRI’s marketing programs, managed care, information technology and facilities management departments at OCSRI.
As the state’s most comprehensive cancer center, OCSRI is home to 21 oncology specialists, 20 advanced practice providers, and over 350 associates, and offers the latest cancer treatment modalities including radiation services, specialty/retail pharmacy, imaging, laboratory, and clinical research. Additionally, the OCSRI oncology network provides extensive services at three regional centers.
Nicolas Ferreyros
Community Oncology Alliance
Nicolas Ferreyros
Thursday, March 23rd; 8:50 – 9:35 AM
The Hospital Conundrum: A Gameplan for Fending Off Attacks & Coexisting, Moderator
Thursday, March 23rd; 1:35 – 2:20 PM
Marketing & Advocacy: Practical Applications of Traditional & Social Media to Elevate Your Practice, Moderator
Friday, March 24th; 11:15 AM – 12:00 PM
Moving From Talk to Action: Implementing & Integrating a Health Equity Plan in Your Practice, Moderator
About the Speaker
Nicolas Ferreyros is Managing Director of Policy, Advocacy, and Communications at the Community Oncology Alliance (COA), the only national organization dedicated solely to preserving and protecting local, affordable, and accessible cancer care. He is responsible for all internal and external communications at COA, including media relations, policy communications, and digital strategy.
A seasoned advocacy and communications strategist with more than 15 years of experience in health care, Nick specializes in developing successful campaigns to address complex issues. He has a deep understanding of the people and processes that affect America’s health care system and has a knack for translating the “wonkery” of health policy into language and concepts that resonate with policymakers, providers, patients, and voters.
Nick has engaged in nearly every major recent health policy issue before Congress and regulatory agencies, including the Affordable Care Act, the 340B Drug Pricing Program, Medicare reimbursement policy, and more. He has worked closely with policymakers on Capitol Hill, the White House, the Department of Health & Human Services, Food and Drug Administration, and National Institutes of Health. Nick’s work has appeared in The New York Times, The Washington Post, The Wall Street Journal, USA Today, CBS Evening News, National Public Radio, and other leading national news outlets.
Prior to joining COA, Nick was a Managing Supervisor at GYMR Public Relations, a boutique Washington, DC communications firm specializing in health care, science, and social issues. While there, he oversaw high-profile, award-winning campaigns for clients including the Robert Wood Johnson Foundation, American Board of Internal Medicine, Consumer Reports, and numerous federal agencies.
A native of Houston, Texas, Nick earned a bachelor’s degree in political science from McGill University in Montreal, Canada. He currently resides in New York City.
Daniel B. Frier, Esq.
Frier Levitt
Daniel B. Frier, Esq.
Thursday, March 23rd; 11:50 AM – 12:35 PM
What Every Practice Needs to Know: The NEW Value-Based Enterprise
About the Speaker
Daniel B. Frier, Esq. co-founded Frier Levitt in 2000, and is the Chair of the Firm’s Healthcare Department. Dan’s practice focuses exclusively on the representation of healthcare clients in transactional, regulatory and corporate matters. With over 20 years of healthcare law experience, his clients include providers and companies in many sectors of the healthcare industry such as physicians, physician groups, pharmacies, hospitals, private equity investors, ambulatory surgical centers and imaging centers, sleep centers and laboratories.
Dan provides clients with strategic advice on how to adjust their operations to keep pace with the quickly changing healthcare marketplace. He works with clients on practice formations and sales, fraud and abuse and Stark counseling, evaluation and structure of business arrangements, buy-sell agreements, employment issues, large group practice mergers, HIPAA compliance, and governmental, Professional Board and medical staff investigations. Dan also represents buyers and sellers in acquisitions of healthcare facilities, physician practices and ancillary businesses. Because so much of healthcare law is federal in nature, Dan has clients across the country, and has a national presence in the formation of large group medical practices.
James Gilmore
American Oncology Network
James Gilmore
Thursday, March 23rd; 2:25 – 3:20 PM
Survive & Prosper: Optimizing Revenue & Increasing Efficiency in Your Practice
About the Speaker
James serves as Chief Pharmacy & Clinical Services Officer at AON. James brings close to 30 years of experience in both clinical and community oncology industry leadership roles. Prior to joining AON, James served as Executive Vice President at Georgia Cancer Specialists in Atlanta, overseeing clinical, pharmacy, research, and imaging operations, as well as financial and strategic planning for 26 outpatient oncology clinics and two retail pharmacies and managing over 500 employees. Heavily involved in national oncology and pharmacy organizations, James is a member of the American Society of Clinical Oncology, Georgia Society of Clinical Oncology, National Community Oncology Dispensing Association, Inc.’s Executive Counsel, ION’s SON Advisory Panel and Precision Medicine Advisory Panel, and is a member of the American College of Healthcare Executives. He is a reviewer for Community Oncology and Advances in Therapy, and has co-authored over 65 published articles and abstracts. After earning his PharmD degree from Mercer University Southern School of Pharmacy, James received advanced clinical training from Georgia Baptist Medical Center in Atlanta.
Lucio N. Gordan, MD
Florida Cancer Specialists & Research Institute
Lucio N. Gordan, MD
Thursday, March 23rd; 8:00 – 8:45 AM
20 Years of COA: The Value of Community Oncology
About the Speaker
Dr. Lucio Gordan earned his medical degree from the State University of Londrina College of Medicine in Londrina, Brazil, and later completed his internship and residency at the University of Iowa Hospitals & Clinics. After finishing his residency, Dr. Gordan was awarded a fellowship in Medical Oncology/Hematology at the University of Florida, Gainesville, FL. He is Board-certified in Medical Oncology, Hematology, and Internal Medicine.
Currently, Dr. Gordan serves as President and Managing Physician at Florida Cancer Specialists & Research Institute (FCS) and practices at the FCS Gainesville Cancer Center. Having served in his previous role as Chief Medical Officer for Therapeutics and Analytics, Dr. Gordan continues to drive precision oncology efforts within the practice through analysis of real-world data, innovative technology, and research. This is Dr. Gordan’s second term as President and Managing Physician, having previously served the statewide practice from 2018-2021.
He also serves as a member of the Executive Council for the National Cancer Oral Dispensing Association (NCODA) and the FCS Executive Board.
As a cancer researcher and the recipient of research grants, Dr. Lucio Gordan is actively engaged in early and late clinical trials. His work has been published in several peer-reviewed journals. He serves on the editorial board of several oncology journals. Dr. Gordan is currently in charge of the development of Digital FCS, real-world evidence division at FCS (PRECISE), therapeutics decisions, and dynamic decision-support tool among other tasks. In 2013, Dr. Gordan was awarded the prestigious FRIST Award from the Hospital Corporation of America (HCA) in recognition of his service in the Gainesville community. He is the co-chair of Humanitarian Initiatives at COA supporting national and international crises and received the 2022 FCS Humanitarian Award, recognizing his efforts on global, national and local scales.
Frequently, he participates in national and international meetings as a speaker and key thought leader. Married and the father of one child, Dr. Gordan enjoys traveling, reading, working in his horse farm and photography.
Erika P. Hamilton, MD
Sarah Cannon Research Institute/Tennessee Oncology
Erika P. Hamilton, MD
Thursday, March 23rd; 11:00 – 11:45 AM
Current Advances: Triple Negative & Locally Advanced Breast Cancer
About the Speaker
Dr. Hamilton received her undergraduate degree from Washington and Lee University in Virginia and received a NCAA Postgraduate Scholarship. She then completed her medical degree and residency from University of North Carolina in Chapel Hill and fellowship training in oncology at Duke University. She joined Sarah Cannon Research Institute as investigator in drug development for women’s cancers in 2013. Since 2015 she has served as the Director of the Breast and Gynecologic Cancer Research Program. She sees patients facing breast cancer from standard of care to phase II/III to phase I drug development.
Dr. Hamilton was named to the Women to Watch Class of 2021 for Nashville Medical News. She serves on the board for local Susan G. Komen. She was selected for ASCO’s Leadership Development Class for 2021-2022, the past Chair of ASCO’s Scientific Committee for Metastatic Breast Cancer for 2019-2020, and currently serves on ASCO’s Cancer Research Committee, the 2023-2025 Scientific Committee Co-Chair of the ESMO Breast Cancer Meeting and is on the Scientific Committee for AACR for 2023. She serves an Associate Editor for Clinical Breast Cancer.
Peter F. Hayes, BA
Healthcare Purchaser Alliance of Maine
Peter F. Hayes, BA
Friday, March 24th; 9:05 – 9:55 AM
The New Horizon: Working Directly with Employers
About the Speaker
Peter Hayes currently the President & CEO of the Healthcare Purchaser Alliance of Maine and formerly a principal of Healthcare Solutions and Director of Associate Health and Wellness at Hannaford Supermarkets. He has been recognized as a thought leader in innovative, strategic benefit design for the past 25+ years. He has received numerous national awards in recognition of his commitment to working collaboratively with healthcare providers and vendors in delivering health benefits that are focused on value (high quality efficient care). He has been successful in this arena by focusing on innovative solutions for patient advocacy, chronic disease management, and health promotion programs.
Peter has also been involved in health care reform leadership roles on both the national and regional levels with organizations like Center for Health Innovation, Care Focused Purchasing, Leapfrog, co-founder of the Maine Health Management Coalition, and been appointed by two different Maine Governors to serve on Health Care Reform Commissions to recommend public policies to improve the access and affordability of health care for Maine citizens.
Brad Hively
The Oncology Institute
Brad Hively
Friday, March 24th; 4:40 – 5:25 PM
Thinking Outside the Box: Going Beyond the “Traditional” Model of the Community Oncology Practice
About the Speaker
Brad Hively is Chief Executive Officer of The Oncology Institute (NASDAQ: TOI). Brad joined TOI as a member of its Board of Directors in 2018 and assumed the role of CEO in 2019. He brings over 20 years of executive leadership and healthcare experience to TOI.
Prior to joining TOI, Brad was President of Health Essentials. Through its IPA, its Medical Group, and its eight hospices, Health Essentials provides high-touch, value-based care for patients with advanced illness.
Before Health Essentials, Brad was Senior Vice President of Operations at Heritage Provider Network. Heritage is one of the largest, most progressive physician groups in the country. Through its network of over 35,000 physicians, Heritage manages care for approximately one million patients on an at-risk basis.
Brad has also spent time as a healthcare investor, holding positions with RLH Equity, General Atlantic, and TA Associates. In his time as an investor, Brad served on the Boards of The Oncology Institute, Biorasi, Patient Care America, and American Access Care.
Brad graduated from UCLA with a bachelor’s degree in Business Economics and earned an MBA from the Stanford Graduate School of Business.
Ben Jones
The US Oncology Network
Ben Jones
Friday, March 24th; 8:05 – 9:05 AM
Legislative Updates From Capitol Hill
About the Speaker
Ben Jones currently serves as Vice President of Government Relations & Public Policy for the McKesson specialty provider organization and The US Oncology Network. In this role, Ben leads the federal and state advocacy efforts around access to care in the community as well as adequate and fair physician reimbursement. Ben has been in this role for over 12 years and serves as the Executive Director of The US Oncology Network political action committee (PAC). Prior to joining McKesson, Ben spent many years in public policy at the state and federal level, including 5 years with the former U.S. House Majority Leader. Ben graduated from the University of Houston with a degree in political science and currently lives in The Woodlands, TX.
Mike Lattanzi, MD
Texas Oncology – Austin Central
Mike Lattanzi, MD
Friday, March 24th; 11:15 AM – 12:00 PM
Current Advances: Genitourinary System Diseases
About the Speaker
Mike Lattanzi, MD is a genitourinary medical oncologist at Texas Oncology – Austin Central. A member of the Sarah Cannon Research Institute / US Oncology Genitourinary Research Committee, he works to expand access to novel therapeutics to community-based cancer patients in Central Texas and nationally.
Dr. Lattanzi attended medical school at the NYU Grossman School of Medicine where he remained to complete internal medicine residency at NYU Langone Health and Bellevue Hospital in New York City. He completed medical oncology fellowship at Memorial Sloan Kettering Cancer Center, focusing on predictive biomarkers and mechanisms of resistance to chemotherapy and immunotherapy in muscle-invasive bladder cancer.
James Lee
Community Oncology Alliance
James Lee
Thursday, March 23rd; 3:50 – 4:35 PM
Updates & Solutions: State & Federal Policies Aimed at Curbing PBM Bad Behavior
About the Speaker
James Lee is senior manager for state regulation and policy at the Community Oncology Alliance (COA), the only national organization dedicated solely to preserving and protecting local, affordable, and accessible cancer care.
An experienced health care advocate at the state and federal levels, James has engaged in successful efforts to expand, clarify, and codify complex policy pertaining to Medicaid, telehealth and telemedicine, behavioral health, and pharmacy, just to name a few.
Prior to joining COA, James represented Legacy Community Health, one of the nation’s largest and fastest growing Federally Qualified Health Center systems, located in Southeast Texas. As manager of government relations at Legacy, he led strategic legislative campaigns with internal and external stakeholders. Producing public policy outcomes for more than 190,000 clients at 45 facilities, he served as a liaison to over 75 federal, state, and local policymakers.
James is a native of the U.S. border with Mexico, and was born and raised in the Rio Grande Valley, the most southern region of Texas. He earned a bachelor’s degree in political science from the University of Houston and now calls Houston home.
Tony Lee
AmerisourceBergen
Tony Lee
Friday, March 24th; 8:05 – 9:05 AM
Legislative Updates From Capitol Hill
About the Speaker
As Director of Public Policy, Tony ensures alignment of policy positions on human and animal health distribution and access to care issues among AmerisourceBergen’s divisions, leadership and the U.S. Public Policy and Advocacy team. His work includes pharmaceutical, medical device and FDA, CMS/HHS, Medicare, Medicaid, ACA (and now IRA) reimbursement and access policies. He has particularly enjoyed helping to secure patient access through policy and advocacy work on reimbursement and operational issues for AB’s Specialty Physician Services division.
His previous experiences includes private healthcare consulting; advancing government affairs at Philips Healthcare; and directing policy and regulatory affairs at NCPA. Tony’s work in private practice has included traditional litigation and corporate, and policy work, including helping to secure appropriations and representing Latin American Embassies. He has also served as Legislative Counsel for a U.S. Senator.
Tony received his JD from Cornell Law School and B.A. degree in Political Science from Yale College. He enjoys singing as a member of the Choral Arts Society of Washington Symphonic and Chamber choirs.
Mike Lefler
Nebraska Hematology-Oncology
Mike Lefler
Thursday, March 23rd; 1:35 – 2:20 PM
Marketing & Advocacy: Practical Applications of Traditional & Social Media to Elevate Your Practice
About the Speaker
Mike Lefler is in his third year serving as Business & Communications Strategist for Nebraska Hematology-Oncology (NHO) in Lincoln, Nebraska. With more than two decades of marketing and communications experience in healthcare, nonprofit organizations, higher education, and collegiate athletics, Mike has found a passion for connecting with audiences of all kinds to direct them to services that enhance their lives. He has led strategic marketing efforts for Doane University, the YMCA of Lincoln, and the American Cancer Society’s Nebraska Region. In the past two years, he has led NHO’s efforts to create a clear and consistent verbal and visual identity by refreshing the brand and brand architecture to accommodate the center’s rapid growth. Mike has previously served on the Board of Directors for his local American Marketing Association and is currently Vice Chair of his local American Cancer Society Board of Directors. In his spare time, he coaches youth volleyball and softball.
Jonathan E. Levitt, Esq.
Frier Levitt
Jonathan E. Levitt, Esq.
Friday, March 24th; 3:50 – 4:35 PM
Updates & Solutions: State & Federal Policies Aimed at Curbing PBM Bad Behavior
About the Speaker
Jonathan E. Levitt, Esq., co-founded the boutique Healthcare law firm of Frier Levitt, LLC in 2000 and the Firm enjoys a national foothold in Life Sciences and Healthcare. Beginning with a 2003 nationwide class action of independent pharmacies, Jonathan began his journey to both understand all aspects of the drug space and develop skills relevant to multiple stakeholders. Frier Levitt has grown to more than 40 Healthcare-focused attorneys, including clinician attorneys, with offices in New York City and Pine Book, New Jersey.
Jonathan has dedicated his practice to representing pharmacies, physician-dispensers, national provider associations, manufacturers, wholesalers, and plan sponsors. He has an established track record of challenging abusive practices of Pharmacy Benefit Managers (PBMs) and speaks at Life Sciences conferences across the country to share his specialized knowledge. Jonathan is the founder of the LinkedIn Group “Hot Topics in Pharmacy Law” and has been published in internationally circulated publications. He commits himself to pro bono and public service assignments and competes in Brazilian Jiu Jitsu.
Richard L. Martin III, MD, MPH
Tennessee Oncology
Richard Lewis Martin III, MD, MPH
Thursday, March 23rd; 2:25 – 3:20 PM
Enhancing Equity in Clinical Research: Lessons Learned From Community Oncology Engagement Efforts
About the Speaker
Dr. Richard Lewis Martin III, MD, MPH is a physician and Medical Director of Health Equity and Community Engagement with Tennessee Oncology, practicing in both Clarksville and Antioch, Tennessee. While not an organ focused specialist, Dr. Martin considers himself a specialist in treating diverse and socially complex patients. Dr. Martin also serves as President of Tennessee Oncology Practice Society (TOPS), the state affiliate of ACCC, where he is leading state efforts to advance patient and provider centered legislation on PBM and Prior Authorization Reform, Telehealth Reimbursement, and Women’s Reproductive Care. He also co-founded and serves on the steering committee for the Appalachian Community Cancer Alliance (ACCA) which seeks to bridge gaps in knowledge, resources, and communication between primary and sub-specialty providers in delivering cancer prevention and screening services. Dr. Martin also serves on COA’s Health Equity Committee.
Dr. Martin’s passion for health equity and caring for underserved populations stems from his initial experiences shadowing physicians in central Washington migrant farmworker clinics, and leading nutrition and exercise programming for low income East Boston Latino families through AmeriCorps. Dr. Martin completed his MPH in Epidemiology and Biostats from Oregon Health Sciences University and his medical school training at the University of Washington School of Medicine, where he sought out clinical rotations in Alaska and Wyoming to better understand rural healthcare delivery. Initially interested in HIV/Hepatitis medicine, Dr. Martin found his calling in Hematology/Oncology during his residency at the University of Wisconsin. During residency, he also discovered his passion for patient and provider advocacy, serving as resident board member of the American College of Physicians Wisconsin Chapter. Appreciating that mentorship and training are critical to advancing DEI, after his residency, Dr. Martin returned to his hometown community residency program for a one-year Teaching Fellowship.
Dr. Martin attended Vanderbilt University Medical Center for his Hematology/Oncology fellowship, where he completed his final year as chief fellow. After completing fellowship, he took a position as Assistant Professor of Medicine at Meharry Medical College, one of four HBCU medical schools in the United States, and tasked with providing oncology care for Middle Tennessee’s safety net hospital, Nashville General Hospital. At Meharry, Dr. Martin served as Co-Director of Clinical Oncology Trials, Sickle Cell Center Medical Director, and Cancer Liaison Physician for the Committee On Cancer. Hoping to build even broader state, regional, and national health equity networks, Dr. Martin joined Tennessee Oncology in 2022 where he now serves as Medical Director of Health Equity and Community Engagement.
When he is not eating, breathing, and sleeping health equity, Dr. Martin prides himself on being husband to his wife Juliana, dad to his son Santiago, and doggie dad to Guacamole. He also finds time to garden, attend Nashville soccer games, and is learning Spanish to keep up with his family.
Jerrica Mathis
Cardinal Health
Jerrica Mathis
Friday, March 24th; 8:05 – 9:05 AM
Legislative Updates From Capitol Hill
About the Speaker
Jerrica Mathis leads the federal Government Relations team as Cardinal Health’s Director, Government Relations. Prior to joining Cardinal Health, Jerrica was a director in Crowell & Moring’s Government Affairs Group. Based in their Washington, D.C. office, she assisted corporate, trade association, and individual clients with legislative and regulatory advocacy and strategies before Congress and federal agencies. Prior to joining Crowell & Moring, Jerrica served as a senior government relations manager at a boutique lobbying shop, where she provided government relations support to health care clients, including global health, non-profit patient advocacy, and health professional organizations. She has also served as a project director at the Society for Public Health Education and as a Congressional Black Caucus Foundation Health Policy Fellow. During her time as a fellow, Jerrica worked on policy issues related to improving the health of racial and ethnic minorities, as well as labor and employer issues, on the U.S. House of Representative’s Committee on Education and Labor and with the office of Representative Donna L. Christensen. Before coming to Washington, D.C., she served in the role of providing technical assistance to state health department chronic disease programs with the National Association of Chronic Disease Directors in Atlanta, GA.
Barbara L. McAneny, MD
New Mexico Cancer Center
Barbara L. McAneny, MD
Thursday, March 23rd; 8:00 – 8:45 AM
20 Years of COA: The Value of Community Oncology
About the Speaker
Barbara L. McAneny, MD, a board-certified medical oncologist/hematologist from Albuquerque, N.M., became the 173rd president of the American Medical Association in June 2018. She has been a member of the AMA Board of Trustees between June 2010 and June 2020, serving as its chair in 2015–2016. Dr. McAneny is a fellow and former member of the board of directors of the American Society of Clinical Oncology (ASCO), a master of the American College of Physicians, and a past president of the New Mexico Medical Society (NMMS), the Greater Albuquerque Medical Association and the New Mexico chapter of the American College of Physicians. In addition, she has served as a member of the Community Oncology Alliance Board of Trustees and on the board of directors of the Cancer Center Business Summit. She became the delegate to the AMA from ASCO in 2002 and was elected to the AMA Council on Medical Service in 2003, serving as its chair in 2009–2010. Dr. McAneny is one of the founders and current chair of the board of the National Cancer Care Alliance, a group of independent practices collaborating to use innovation to deliver high-quality, high-value cancer care and to develop new alternative payment models based on sound data-driven principles. Prior to this, she was a founding member of Oncology Circle, a group of oncology practices using data to promote best practices. Dr. McAneny’s interest in using data to improve practice sustainability began when she was appointed to the Centers for Medicare & Medicaid Service’s Practicing Physicians Advisory Council, where she served from 2002 to 2006. In 2012 Dr. McAneny received a $19.8 million grant from the Centers for Medicare & Medicaid Innovation to demonstrate how oncology practices could use triage pathways to dramatically lower costs while improving outcomes. This award, named COME HOME (for Community Oncology Medical Home), later was incorporated into Medicare’s Oncology Care Model. Dr. McAneny also co-founded New Mexico Oncology Hematology Consultants Ltd. in 1987 with Clark Haskins, MD. A managing partner since 1999, she built New Mexico Cancer Center as the first physician-owned multi-disciplinary cancer center in the state with clinics in Albuquerque and Gallup. She also founded the New Mexico Cancer Center Foundation, which provides grants to help patients with nonmedical expenses. Dr. McAneny graduated magna cum laude from the University of Minnesota in 1973 and with honors from the University of Iowa College of Medicine in 1977. She completed her residency in internal medicine at the University of Iowa in 1980 and her fellowship in hematology/oncology at the University of New Mexico in 1983. She is married to Steven Kanig, MD.
Jeff Mortier
Farragut Partners
Jeff Mortier
Thursday, March 23rd; 3:50 – 4:35 PM
Updates & Solutions: State & Federal Policies Aimed at Curbing PBM Bad Behavior
About the Speaker
Jeff Mortier brings over a decade of public policy expertise in the healthcare, energy, telecommunications, privacy, and data security arenas and is widely regarded as a trusted voice on Capitol Hill.
Jeff has extensive experience in providing strategic advice and lobbying and policy expertise to executives of fortune 500 companies, industry associations, and non-profit organizations.
Jeff also serves as the Executive Director of the 21st Century Privacy Coalition, where he represents major telecommunications and cable companies.
Prior to co-founding Farragut Partners, Jeff served as a Professional Staff Member on the House Energy & Commerce Committee under Chairman Fred Upton (R-MI). In that role, he helped organize the committee’s policy agenda and promoted the Chairman’s legislative priorities including work on online privacy and data security issues. He also served as a liaison to Republican Member offices on the committee and worked directly with Members and senior staff to help them further their policy goals.
Before serving on the Energy & Commerce Committee, Jeff spent five years working with senior Member of Congress Rep. Ed Whitfield (R-KY) where he handled the Congressman’s most important legislative priorities, including health care policy, and served as Rep. Whitfield’s top policy advisor. During his time with Rep. Whitfield, Jeff worked on a number of significant bills including the Patient Protection and Affordable Care Act, the Food and Drug Administration Amendments Act of 2007 and the Food Safety and Modernization Act.
Working with his founding partners, Jeff MacKinnon and Joe Vasapoli, Jeff has built Farragut Partners into a premier DC lobbying firm. A Louisiana native, Jeff resides in Washington, DC with his wife Nicole.
Todd O’Connell
New York Cancer & Blood Specialists
Todd O'Connell
Thursday, March 23rd; 2:25 – 3:20 PM
Survive & Prosper: Optimizing Revenue & Increasing Efficiency in Your Practice
About the Speaker
Todd O’Connell is the President of New York Cancer and Blood Specialists (NYCBS), where he has been instrumental in the growth and success of the practice since 2016. With over 20 years of experience in management, Todd brings a wealth of knowledge to NYCBS, covering areas such as accounting, financial operations, clinical administration, and business development. He implements organizational strategies and continuously evaluates and improves processes and procedures.
Todd is a well-educated professional, having earned a Bachelor’s degree in Business Administration and a minor in Communication Studies from the University of Nebraska-Lincoln in 1999, and a Master of Science in Medical Group Administration from Nebraska Methodist College-Omaha in 2008. He is a certified medical practice executive (CMPE) and serves on various boards, including the Board of Directors of Community Oncology Alliance, the International Oncology Network (ION) Advisory Council, and the New York Cancer Foundation, where he also holds the position of Treasurer. Todd also served as the Interim Chief Operating Officer for OneOncology from 2020-2021.
In his free time, Todd enjoys playing golf and spending time with his family.
Ted Okon, MBA
Community Oncology Alliance
Ted Okon, MBA
Thursday, March 23rd; 8:00 – 8:45 AM
20 Years of COA: The Value of Community Oncology, Moderator
Friday, March 24th; 8:05 – 9:05 AM
Legislative Updates From Capitol Hill, Moderator
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology, Moderator
About the Speaker
Ted Okon is a nationally recognized expert on the policy and politics of cancer care. He is quoted extensively in the press, including guest appearances on TV and radio news shows. Ted has testified before Congress on cancer issues and is frequently on Capitol Hill discussing the nation’s cancer care delivery system. Ted’s target areas of expertise include the cost of cancer treatment, health care reform, Medicare reimbursement, pharmacy benefit managers (PBMs), drug shortages, and the changing landscape of cancer care delivery in the United States.
Ted has dedicated his career to healthcare business and policy. He has worked for several pharmaceutical companies including Merck and Warner-Lambert, now part of Pfizer, and IMS Health. He co-founded and took public the health care information business Medical Marketing Group. He also founded two oncology companies (an oncology clinical research network and an information network) and has traveled extensively to China, India, Singapore, the U.K., and the Middle East, analyzing and discussing cancer care delivery.
As executive director of the Community Oncology Alliance (COA), Ted oversees the strategic direction of this non-profit organization dedicated to patients and providers in the community cancer care setting, under the direction of a dedicated board of oncologists and practice administrators. Ted also travels the country speaking to state oncology societies, professional organizations, and companies about the challenges facing the nation’s cancer care delivery system. He has authored numerous articles and studies relating to cancer care policy and politics, reimbursement, and clinical issues.
Ted holds a BS degree from Fairfield University and an MBA from the Carnegie-Mellon University Tepper School of Business. His wife, Susan, practiced as a certified oncology nurse.
Amber Orman MD, DipABLM
AdventHealth Medical Group
Amber Orman MD, DipABLM
Friday, March 24th; 10:25 – 11:10 AM
Empowering Cancer Patients Through Lifestyle Medicine: An Innovative Approach to Wellness
About the Speaker
Amber Orman, MD, DipABLM is a double board-certified radiation oncologist and lifestyle medicine specialist focusing on breast cancer treatment and prevention. She is the first ever Chief Wellness Officer (CWO) of AdventHealth Medical Group, working to improve the well-being of her colleagues. She is also the co-founder of the HEAL (Healthy Eating and Active Lifestyle) program at AdventHealth in Orlando, Florida. HEAL is an 8-week lifestyle medicine program designed to educate and inspire cancer patients to make positive changes to decrease cancer recurrence and improve overall healthspan. She collaborates with the American College of Lifestyle Medicine as a member of the Health Systems Council and also serves as the Chair of the Cancer Member Interest Group.
She is a mother to 3 teenagers and 2 poodles, wife to a witty nephrologist, loves her daily yoga, and spends her free time trail running and summiting Colorado’s peaks.
Kashyap Patel, MD
Carolina Blood & Cancer Care Associates
Kashyap Patel, MD
Friday, March 24th; 11:15 AM – 12:00 PM
Moving From Talk to Action: Implementing & Integrating a Health Equity Plan in Your Practice
About the Speaker
Kashyap Patel, is the CEO of Carolina Blood and Cancer Care Associates. Dr. Patel is a full time practicing medical oncologist, board certified in Hematology, Oncology, and Internal Medicine. He is president for the Community Oncology Alliance (COA). He is also chairman of the newly formed Biosimilars committee for the COA. He is a chairman for the clinical affairs and trustee for the Association of Community Cancer Centers (ACCC). He is also a member of the CPC committee for the ASCO. He has been an advisor for the large payers including DHHS (SC), Palmetto GBA. He also serves on and advisory board for Medicaid HMOs. He has a special interest in health care policy and economics and the end of life care. He recently joined International oncology network as medical director. He has expertise in Value Based Care and has successfully led Oncology Care Model pilots with two payers including with CMMI (new division of CMS).
Dr. Patel is the Associate Editor in Chief for the AJMC and Evidence Based Oncology.
He is a certified trainer for physicians “Education in Palliative and End of life Care” and has been a speaker at several different CME events. He is involved in healthcare economics and is working with major commercial payer on AAPM. He is also contractor medical director for Palmetto GBA (consultant). He is past president of the South Carolina Oncology Society. He has been working directly with cancer patients for the last twenty years. He has served as chairman of several committees in numerous South Carolina hospitals. He has had extensive research experience in the field of oncology and have published and presented articles in journals (nationally and internationally) and has had research merit awards for research in cancer including ASCO merit awards during fellowship.
Dr. Patel has extensive legislative experience both at the local and national level. He has testified in state senate as well as has carried out capitol hill briefing on precision medicine. He has also carried out senate and congressional staff briefing on multiple issues.
Payal Patel, EMBA, MBA, MHA
Adams County Cancer Center
Payal Patel, EMBA, MBA, MHA
Friday, March 24th; 12:55 – 1:45 PM
Securing Your Practice: Dealing With Cyberattacks & Other Disasters
About the Speaker
Payal Patel, EMBA, MBA, MHA is the CEO for the Adams County Cancer Center, Clermont County Cancer Center, and Scioto County Cancer Center located in south eastern Ohio for the past 11 years. She holds a EMBA from the University of Kentucky and the University of Louisville – a dual university program, and her MBA and MHA from the University of Phoenix.
She is an active member of COA (Community Oncology Alliance) and POHMS (Premier Oncology Hematology Management Society). She is a board member for CHOC (Community Hematology Oncology Consortium) and became a co-treasurer in the winter of 2022.
Jeffrey F. Patton, MD
One Oncology & Tennessee Oncology
Jeffrey F. Patton, MD
Thursday, March 23rd; 8:00 – 8:45 AM
20 Years of COA: The Value of Community Oncology
About the Speaker
Jeff Patton, MD, is a board-certified hematologist and oncologist, Chief Executive Officer and Board Member at OneOncology, where he also served as President of Physician Services for over a year. His primary mission is to improve the lives of everyone living with cancer. Dr. Patton is leading OneOncology in growing their advanced partnership of top community oncology practices and positioning them to support the entire continuum of cancer care in any reimbursement environment.
Dr. Patton practiced with Tennessee Oncology, one of the nation’s leading oncology practices, for 24 years. He is currently the Chairman of the Board and served as CEO of Tennessee Oncology for a decade (2010-2020). Dr. Patton is also an active member of the American Society of Clinical Oncology (ASCO), Tennessee Oncology Practice Society (TOPS), and is a board member and member of the executive committee of Community Oncology Alliance (COA).
Meredith Pelster, MD, MSCI
Sarah Cannon Research Institute/Tennessee Oncology
Meredith Pelster, MD, MSCI
Thursday, March 23rd; 1:35 – 2:20 PM
Current Advances: Systemic Therapies for Upper GI Cancers
About the Speaker
Dr. Pelster joined Sarah Cannon in 2021 and serves as assistant director of gastrointestinal (GI) research for Sarah Cannon Research Institute at Tennessee Oncology, specializing in GI cancer as well as head and neck cancer research.
Dr. Pelster received her Doctorate of Medicine from Vanderbilt University. She completed her fellowship in hematology and medical oncology at the MD Anderson Cancer Center and her residency and Masters of Science in clinical investigation at Northwestern University.
Shiela Plasencia
Community Oncology Alliance
Sheila Plasencia
Friday, March 24th; 10:25 – 11:10 AM
HR Keys to Success: Attracting & Retaining Physicians & Staff, Avoiding Burnout & Maintaining a Productive Work Environment, Moderator
Friday, March 24th; 12:55 – 1:45 PM
Securing Your Practice: Dealing With Cyberattacks & Other Disasters, Moderator
About the Speaker
As Director of Practice Support, Shiela Plasencia brings a wealth of knowledge to COA membership. Ms. Plasencia acts as a critical link between practice administrators, distributing insights and tools to improve practice operations and pursue the highest quality care for patients. She also oversees the COA Administrators’ Network, a peer-to-peer network for administrators for practice leaders to share best practices for addressing the unique issues they face.
Prior to joining COA, Plasencia served as director of quality improvement, compliance, and value-based care at Oklahoma Cancer Specialists and Research Institute (OCSRI), a community oncology practice she joined in 2004. Through her leadership, OCSRI earned the American Society of Clinical Oncology’s QOPI Certification and is one of only two practices in the state of Oklahoma to hold this certification. In 2016, Plasencia joined the Coalition of Hematology Oncology Practices (CHOP) and currently serves as its immediate past president.
Anne Marie Rainey, MSN, RN, CHC
Clearview Cancer Institute
Anne Marie Rainey, MSN, RN, CHC
Thursday, March 23rd; 8:50 – 9:35 AM
The Hospital Conundrum: A Gameplan for Fending Off Attacks & Coexisting
Thursday, March 23rd; 11:00 – 11:45 AM
Practice Perspectives: The Enhancing Oncology Model & Commercial Payment Reform Initiatives
About the Speaker
Anne Marie Rainey, MSN, RN, CHC, is the Director of Quality and Value-Based Care at Clearview Cancer Institute in Huntsville, Alabama and manages internal quality, government, and value-based care programs. She has experience in government quality reporting as a contractor for Centers for Medicare and Medicare Services and Centers for Disease Control. After obtaining her MSN in leadership and administration, Anne Marie transitioned to community oncology. Her work interests include quality metrics analysis, program implementation, health policy, and community oncology advocacy. Anne Marie has several publications about implementation of value-based care initiatives, including Oncology Care Model, and has participated in speaking engagements sharing learnings. She has the privilege of serving on several boards, committees, and taskforces with Association of Community Cancer Centers and Community Oncology Alliance to promote best practices and positively impact community oncology. Anne Marie resides in Alabama with her husband, twins, and dog. She loves mission work, volunteering, is an avid college football fan, and enjoys traveling.
Erin Reinders, PHR, SHRM-CP
Iowa Department of Administrative Services, Human Resources Enterprise
Erin Reinders, PHR, SHRM-CP
Friday, March 24th; 9:05 – 9:55 AM
The New Horizon: Working Directly with Employers
About the Speaker
Erin Reinders is the Chief Operations Officer (COO) for the Human Resources Enterprise of the Department of Administrative Services providing operational direction and leadership for HR programs, services and guidance on policy management for the State of Iowa Executive Branch. She has more than 21 years of human resources experience in the public and private sector. Throughout her career, she has worked in several areas of human resources including employee relations, labor relations, training, safety, policy and procedures development, and benefit administration. Erin earned a bachelor’s degree in business administration from Iowa State University.
Gregory J. Riely, MD, PhD
Memorial Sloan Kettering Cancer Center
Gregory J. Riely, MD, PhD
Thursday, March 23rd; 11:50 AM – 12:35 PM
Current Advances: Lung Cancer
About the Speaker
Dr. Gregory Riely is a medical oncologist in the Department of Medicine at Memorial Sloan Kettering Cancer Center. Dr. Riely received his PhD and MD degrees from Case Western Reserve University, was a Resident in Internal Medicine at NY Presbyterian/Weill Cornell and completed fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer. His primary research focus is in clinical and translational research to advance the care of patients with non-small cell lung cancer. He is a principal investigator for numerous early phase clinical trials and is co-principal investigator for the AACR’s Project GENIE Biopharma Collaborative.
Michelle Robey
Florida Cancer Specialists & Research Institute
Michelle Robey
Thursday, March 23rd; 1:35 – 2:20 PM
Marketing & Advocacy: Practical Applications of Traditional & Social Media to Elevate Your Practice
About the Speaker
Michelle is a skilled and talented marketing communication executive with over 25 years of leadership experience in both healthcare and agency settings. Since joining FCS in 2019 as Director of Marketing & Communications, Michelle has devised and implemented numerous impactful external and internal initiatives and campaigns.
Prior to joining FCS, Michelle served for five years as Director of Marketing for AdventHealth Tampa and as Vice President of the Healthcare Provider Team with Hill & Knowlton Strategies in Tampa. She previously held positions with Humana Inc. and Norton Healthcare Inc. in
Louisville, KY.
She holds a B.A. in Mass Communications and Political Science from Purdue University.
Her industry awards have included national and international recognition from the American Marketing Association, Healthcare Marketing Report, the American Advertising Federation, the Hermes Creative Awards, and The Telly Awards.
Michelle directs all marketing and communications strategies and activities to strengthen the FCS brand and support the company’s long-term growth initiatives. She oversees branding, advertising, and internal and corporate communications functions on behalf of the statewide oncology practice.
She and her husband, Doug, reside in Bradenton, FL along with their three Goldendoodles. They enjoy boating, golfing, and traveling.
Kristine Rufener
Association for Clinical Oncology
Kristine Rufener
Friday, March 24th; 8:05 – 9:05 AM
Legislative Updates From Capitol Hill
About the Speaker
Kristine Rufener is the Director of Congressional Affairs, representing the Association for Clinical Oncology (ASCO) on a plethora of healthcare issues before the U.S. Congress. As an experienced lobbyist, Kristine joined ASCO in 2021 after spending the previous decade as a government relations professional in Washington, D.C., advocating for physicians and the patients for whom they care. She is responsible for developing and implementing comprehensive advocacy strategies to advance ASCO’s legislative agenda. She earned a bachelor’s degree in Political Science from Calvin College in Grand Rapids, MI.
Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC
Oncology Consultants
Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC
Friday, March 24th; 11:15 AM – 12:00 PM
Moving From Talk to Action: Implementing & Integrating a Health Equity Plan in Your Practice
About the Speaker
Susan is the Executive Director of Clinical Strategy at Oncology Consultants in Houston, TX. She develops and implements innovative clinical strategies and policies that lead to the growth of Oncology Consultants, the largest, community-based Hematology/Oncology practice in Houston and South Texas. Susan has created nursing and operations protocols for all levels of oncology staff. She has established an appropriate framework and oversight including input into strategy, prioritization, resourcing, reviews, and decision making to innovate around consumer-focused oncology programs. Developing a community based oncology nurse navigation program and collaborating to implement a fully integrated initiative to address social determinants of health within the practice have been critical projects in her role.
Committed to holistic, patient-centric care, Susan has dedicated time to patient advocacy and health disparities, especially as they relate to cancer management. She has been asked to speak on various panels addressing the complex issues surrounding health equity. She currently sits on the COA Patient Advocacy Network (CPAN) Advisory Panel, and the Houston Cancer Health Equity Collaborative. She is an advisor to the Health Equity & Access Committee for the Texas Society of Clinical Oncology (TxSCO) and sits on the panel for the COA Health Equity Committee.
Susan holds a Bachelor of Science in Nursing from the University of Pittsburgh and a Master of Science in Nursing Administration from the University of Texas at Arlington.
Amir Salam, MD
Oncology Consultants
Amir Salam, MD
Friday, March 24th; 10:25 – 11:10 AM
HR Keys to Success: Attracting & Retaining Physicians & Staff, Avoiding Burnout & Maintaining a Productive Work Environment
About the Speaker
Dr. Amir Salam practices Medical Oncology with Oncology Consultants with clinic locations in League City, Pasadena, and Pearland. He grew up in the Clear Lake area, only to return home to begin his practice after completing medical training throughout several major academic centers in Texas. He is a member of the American Society of Clinical Oncology, American Society of Hematology, the Harris County Medical Society, and the Texas Medical Association. He has been awarded “Teacher of Distinction” for his dedication to teaching medical students during their clinical rotations and continues to serve as a Clinical Assistant Professor at the University of Texas Medical Branch. He has appeared on radio talk shows and community events to help share his experiences as someone who has valued providing care to cancer patients through all aspects of their journey. During his off time, he enjoys cooking, reading, exercising, and attending his daughters’ endless extracurricular activities.
Todd Schonherz
American Oncology Network
Todd Schonherz
Friday, March 24th; 12:55 – 1:45 PM
Securing Your Practice: Dealing With Cyberattacks & Other Disasters
About the Speaker
With more than 30 years of healthcare experience and as AON’s CEO, Todd is responsible for overseeing AON’s mission and strategy. Under his leadership, Todd has successfully built a leading oncology platform resulting in over $1 billion in revenue. The AON network now includes more than 190 providers in over 70 clinics across 18 states. In his previous role as Florida Cancer Specialists (FCS) Chief Operating Officer, he was responsible for the day-to-day operations within the corporate office and nearly 100 locations throughout Florida. Prior to his role as COO of FCS in 2011, Todd was Senior Vice President and Chief Information Officer for US Oncology. As part of the senior management team, Todd helped set organizational goals and objectives, oversaw strategic project prioritization, and led tactical execution of company-wide initiatives. Todd received a bachelor’s degree in health policy and administration from Pennsylvania State University. Todd has presented at national industry conferences including multiple Community Oncology Alliance (COA) conferences as well as national and regional information technology conferences.
Matthew R. Skelton, MD
Blue Ridge Cancer Care
Matthew R. Skelton, MD
Thursday, March 23rd; 11:00 – 11:45 AM
Practice Perspectives: The Enhancing Oncology Model & Commercial Payment Reform Initiatives
About the Speaker
Dr. Matthew R. Skelton graduated with a Bachelor of Science from Fordham University in New York, New York. He received his M.D. from Jefferson Medical College in Philadelphia, Pennsylvania in 2001. He completed his internal medicine residency at the Mayo Clinic in Minnesota and his hematology/oncology fellowship at the University of North Carolina in Chapel Hill, North Carolina. Dr. Skelton is board certified in oncology, hematology, internal medicine and palliative care. Dr. Skelton is an active committee member of the ASCO Oncology Medical Home, ASCO OMH Pilot Certification Process, US Oncology Value Based Care National Committee. Finally, he participates in the US Oncology Value Pathways Task Force. Dr. Skelton serves as the Physician champion for the value based care at Blue Ridge Cancer Care.
Dr. Skelton is married with three kids and enjoys hiking, skiing and reading spy novels in his free time.
Elizabeth Spurlock, MA, SHRM-SCP, PHR
Texas Oncology
Elizabeth Spurlock, MA, SHRM-SCP, PHR
Friday, March 24th; 10:25 – 11:10 AM
HR Keys to Success: Attracting & Retaining Physicians & Staff, Avoiding Burnout & Maintaining a Productive Work Environment
About the Speaker
Elizabeth Spurlock is the Director, Human Resource Business Partner for Texas Oncology. She partners with Texas Oncology leaders to ensure business objectives are supported and exceeded through value based HR programs. Elizabeth’s approach to HR is more strategic in nature, challenging traditional HR approaches. Known as a disruptor in some instances, she aims to deliver and accelerate positive change through relationship and data driven methodologies.
Prior to her current role, Elizabeth served as Director, Talent Partner supporting the Corporate Functions of McKesson and has served as a Sr. Manager, Talent Assessment, as well. Prior to McKesson, she led in different capacities at Trinity Industries, such as: leading the training & development team, leadership strategy and development, assessment utilization and insights, data analytics and statistical modeling, succession planning, diversity and inclusion strategies, change management, org design and development.
Elizabeth has a Master of Arts in Industrial and Organizational Psychology, and currently working towards obtaining her PhD in Industrial Organizational Psychology, specializing in Inclusive Leadership. She is a member of SIOP (Society for Industrial and Organizational Psychologists), DAIOP (Dallas Area Industrial and Organizational Psychologists), and the OD Network.
She and her husband, Ryan, are proud parents to Ryan, Jr. (age 2) and 3 chickens. The Spurlock family enjoys cooking, camping, fishing, and enjoying all things outdoors with friends and family.
Phil Stover
Mission Cancer + Blood
Phil Stover
Friday, March 24th; 9:05 – 9:55 AM
The New Horizon: Working Directly with Employers
About the Speaker
Phil Stover is the Chief Executive Officer of Mission Cancer + Blood, PLLC. Mission Cancer proudly serves Patients in three main locations in Des Moines, Iowa as well as through 22 outreach clinics spanning the entire state. Phil is humbled by the opportunity to work for this amazing group as CEO and to be able to have the opportunity to serve the physicians and staff that are dedicated to treating those suffering from cancer.
Phil is an accomplished businessman and attorney with over 20 years of experience in business development, management, operations, revenue cycle, revenue optimization, business process improvement, negotiations, and contracting. Phil graduated from Drake University Law School with a Juris Doctorate Degree with Honors and is licensed to practice law in the state of Iowa. Phil also completed the University of Iowa Executive MBA program and received his Master of Business Administration degree with Distinction. Phil has successfully served his clients and businesses in the roles of CEO, COO, General Counsel, Program Manager, Consulting Business Advisor, and Lead Negotiator. In 2007, Phil received the prestigious “Forty under 40” Award from the Des Moines Business Record recognizing his leadership skills and outstanding accomplishments. In short, Phil is driven, highly personable, hard-working, resilient, and tenacious.
TR Strickland
Alternative Payment Model/Value-Based Consultant
TR Strickland
Thursday, March 23rd; 11:00 – 11:45 AM
Practice Perspectives: The Enhancing Oncology Model & Commercial Payment Reform Initiatives
About the Speaker
TR Strickland is a strategic leader focused on creating market value in healthcare over the past 13 years including medical device, healthcare technology, and recently in value-based oncology specifically in developing Alternative Payment Models (APMs). TR has proven success in delivering successful outcomes in Alternative Payment Models across the payer continuum, including CMS (OCM), Commercial, Medicare Advantage and direct to MSO VBC programs.
Prior to entering healthcare, TR served in the US Army as a Captain and awarded 2 Bronze stars for Meritorious Service.
TR has a MBA with an emphasis in Finance and Accounting and a certified PMP from the Project Management Institute. TR currently resides in Orlando Florida.
S. McDonald Wade III, MD
Virginia Cancer Institute
S. McDonald Wade III, MD
Thursday, March 23rd; 8:50 – 9:35 AM
The Hospital Conundrum: A Gameplan for Fending Off Attacks & Coexisting
About the Speaker
Dr. Wade is a proud Virginian, and proud to be a board-certified oncologist with the Virginia Cancer Institute. He advocates our unique mix of cutting-edge research and compassionate care that make VCI a celebrated institution in Central Virginia. His clinical and research interests are pancreatic, lung and colon malignancies.
Dr. Wade is a Richmond native and received his medical training entirely in and around the Central Virginia area. Beginning with a BA from the University of Virginia in Charlottesville, VA in 1995, he returned to Richmond to earn his MD from Virginia Commonwealth University School of Medicine in 2001. He then remained at VCU Medical Center to complete both a residency in internal medicine and a fellowship in hematology/oncology. He is board-certified in internal medicine and medical oncology and is a member of the Medical Society of Virginia, the Richmond Academy of Medicine and the American Association of Clinical Oncology. He has been a physician with the Virginia Cancer Institute since 2007. He sees patients at our Mechanicsville location.
Outside the office, Dr. Wade enjoys spending time with his family at their Richmond home. Staying in shape is important to him. You’re likely to find him rooting for his alma mater—UVA—courtside, at the stadium or on television. He’d like to assure his Hokie-fan patients that there are no teams when it comes to cancer treatment. He treats all his patients like family—even Virginia Tech fans.
Jodi Young
Texas Oncology
Jodi Young
Thursday, March 23rd; 8:50 – 9:35 AM
The Hospital Conundrum: A Gameplan for Fending Off Attacks & Coexisting
About the Speaker
She is responsible for managing operations of over 20 clinics for Texas Oncology, P.A., as well as strategic planning for all of Texas Oncology. Jodi specializes in communication with her operational team to drive results for the organization. She has a special interest in strategic planning to help the organization and various parts of the organization define and align goals and objectives that contribute to the future vision of the organization.
Prior to joining Texas Oncology in 2010, Jodi worked in business development for a large hospital system in Austin, Tx. With her background in both hospital and community-based care, she has been able to develop relationships with the hospital systems to drive collaborative engagement to support the delivery of community oncology services.
Jodi earned an undergraduate degree in arts and science from Texas State University and a Master of Healthcare Leadership (MHL) from Western Governors University.
Conference Co-Chairs
Stephen “Fred” Divers, MD
Genesis Cancer & Blood Institute & American Oncology Network
Stephen “Fred” Divers, MD
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Thursday, March 23rd; 3:50 – 4:35 PM
Thinking Outside the Box: Going Beyond the “Traditional” Model of the Community Oncology Practice, Moderator
Friday, March 24th; 7:30 – 8:00 AM
Conference Opening Day Two: Update From the Co-Chairs
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
About the Co-Chair
Dr. Divers received his medical degree from Louisiana State University where he was a selected as a member of Alpha Omega Alpha. He completed his residency in Internal Medicine at the University of North Carolina at Chapel Hill. During his tenure there, he was named the Outstanding Resident all three years and received the Chairman’s award for his performance in medicine. He completed a dual fellowship in Hematology and Oncology at University of Alabama, where he conducted clinical trials in combined modality therapy for lung cancer and translational research with gene arrays and immune checkpoint therapy. He was honored as the Outstanding Clinical Fellow and Outstanding Research Fellow while in Alabama. Following completion of his training, he joined Genesis Cancer Center in Hot Springs, Arkansas in 2004 as a practicing physician. Locally, he served as Chief of Staff for CHI ST Vincent hospital and Chairman of the Cancer committee. He was instrumental in founding the CPAN chapter for patient advocacy in in Arkansas. He has continued clinical research in the private setting, publishing data from multiple trials involved with cell free DNA sequencing and therapeutics. He continues to serve as a member of the ION advisory panel and on the Community Oncology Alliance as an active board member and Co-Chair for the annual conference. He and his partners joined American Oncology Network in 2018 with a group from Louisiana as the founding practices. He is currently Chairman of the Advisory board for AON, and remains passionate about the success of community oncology.
Kathy Oubre
Pontchartrain Cancer Center
Kathy Oubre
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Friday, March 24th; 7:30 – 8:00 AM
Conference Opening Day Two: Update From the Co-Chairs
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
About the Co-Chair
Kathy Oubre is the CEO of Pontchartrain Cancer Center in Louisiana.
Kathy is a board member of the Community Oncology Alliance and co-chairs the Biosimilars committee and serves on their Government Affairs committee. Kathy chairs the NCODA Oncology Institute. She also serves on the Strategic Advisory committee and Leadership Council for Flatiron Health. Kathy is a member of ACCC and serves on their Oral Oncolytics Advisory committee. She is a member of the national MGMA and serves on their government affairs group. She is also the past president for the Louisiana MGMA and chairs their government affairs committee. Kathy also serves on the editorial boards for The Center for Biosimilars and Evidence-Based Oncology.
Debra Patt, MD, PhD, MBA
Texas Oncology & The US Oncology Network
Debra Patt, MD, PhD, MBA
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Friday, March 24th; 7:30 – 8:00 AM
Conference Opening Day Two: Update From the Co-Chairs
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
About the Co-Chair
Dr. Debra Patt is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. She is an active leader in breast cancer and research in healthcare informatics.
Dr. Patt has responsibility for breast cancer research in Austin and leads our multidisciplinary tumor boards for breast cancer.
As an expert in healthcare policy, she has testified before Congress to protect access to care for Medicare beneficiaries. She chairs the Council on Legislation for the Texas Medical Association and works to formulate responsible healthcare policy that improves the health of Texans. She serves as the Editor in Chief of the Journal of Clinical Oncology Clinical Cancer Informatics, and drives engagement in clinical informatics solutions to enhance healthcare. Her research is in clinical decision support, predictive analytics, telemedicine, HEOR, tools for patient symptom management and quality improvement.
Within Texas Oncology, she serves on the payer relations, marketing, telemedicine, strategy, policy, management executive, marketing, and revenue cycle committees.
She is the past-chair of ASCO’s clinical practice committee and served on ASCO’s nominating committee for the ASCO Board and the Conquer Cancer Foundation as well as the health IT work group, EHR, technology, and data requirements workgroup, and guidelines committees.
Dr. Patt serves as the President of the Texas Society of Clinical Oncology, the Vice President for the Community Oncology Alliance and serves locally on the Austin Healthcare Council, Shivers Board, and formerly on the board of Komen and the Breast Cancer Resource Center.
She lectures medical students and is a clinical Professor at Dell Medical School at The University of Texas at Austin.
Alti Rahman MHA/MBA, CSSBB
Oncology Consultants
Alti Rahman MHA, MBA, CSSBB
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Thursday, March 23rd; 4:40 – 5:25 PM
Thinking Outside the Box: Going Beyond the “Traditional” Model of the Community Oncology Practice
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
About the Co-Chair
Alti is the Practice Administrator for Oncology Consultants. He holds a dual Masters degree in Healthcare and Business Administration from the University of Houston and is a Certified Six Sigma Black Belt (CSSBB).
Oncology Consultant’s has 14 Medical Oncology offices. Ancillary services include 2 Radiation Oncology office, 2 Diagnostic Imaging centers, 3 Retail Pharmacy’s, and Clinical Research programs all supported by a central administrative office.
Alti holds additional roles including: Six Sigma course instructor for Medical Group Management Association (MGMA), Board Member of COA (Community Oncology Alliance) and Co-Chair of the COA Administrator Network (CAN), Treasurer for the National Cancer Care Alliance (NCCA), Steering Committee Member for McKesson Specialty Health, Board Member of the Oncology Circle Advisory, and President of the Coalition of Hematology and Oncology Practices (CHOP).
Stephen Schleicher, MD, MBA
Tennessee Oncology
Stephen Schleicher, MD, MBA
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Friday, March 24th; 7:30 – 8:00 AM
Conference Opening Day Two: Update From the Co-Chairs
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
About the Co-Chair
Stephen Schleicher, MD, MBA, was appointed Chief Medical Officer (CMO) of Tennessee Oncology, one of the largest providers of oncology care in the country and the largest in Tennessee, in January 2022. In that role, Dr. Schleicher oversees clinical programs to promote the high-quality, innovative and patient-centered care Tennessee Oncology is known for delivering throughout Tennessee and North Georgia. Prior to this, Stephen served as Medical Director of Value-Based Care across both Tennessee Oncology and OneOncology, a national platform for independent community oncology practices that now includes over 700 oncology providers across the US. Dr. Schleicher received his medical training from Harvard’s Brigham and Women’s Hospital and Memorial Sloan Kettering (MSK) in New York before returning to his hometown of Nashville to join Tennessee Oncology. Dr. Schleicher also spent time as a consultant at McKinsey and Company and received his MBA from Harvard Business School. In addition to his role as CMO for Tennessee Oncology, Dr. Schleicher serves as President of the Tennessee Oncology Practice Society.
Jeffrey Vacirca, MD, FACP
New York Cancer & Blood Specialists & OneOncology
Jeffrey Vacirca, MD, FACP
Thursday, March 23rd; 7:30 – 8:00 AM
Conference Opening Day One: From the Co-Chairs
Thursday, March 23rd; 11:50 AM – 12:35 PM
What Every Practice Needs to Know: The NEW Value-Based Enterprise
Friday, March 24th; 7:30 – 8:00 AM
Conference Opening Day Two: Update From the Co-Chairs
Friday, March 24th; 1:50 – 2:35 PM
Looking Into the Crystal Ball: Tomorrow & the Next 20 Years of Community Oncology
Friday, March 24th; 2:40 – 2:55 PM
Conference Wrap-Up: Meeting Observations From the Co-Chairs
About the Co-Chair
Jeffrey Vacirca, MD, FACP is a board-certified hematologist and oncologist, serving as Chief Executive Officer and managing partner at New York Cancer & Blood Specialists. Dr. Vacirca is the immediate past president of the Community Oncology Alliance (COA) and is the medical director for the International Oncology Network (ION), Oncology Network Development at Mt. Sinai Health Network, and for Long Island Aids Care (LIAC). Dr. Vacirca serves on the board of directors of OneOncology, BeyondSpring, and the American Red Cross of Greater New York.
Dr. Vacirca is the founder and chairman of the New York Cancer Foundation, which provides financial assistance to patients undergoing cancer treatment. He is also co-founder and former vice-chairman of Odonate Therapeutics, and director and chair of the Compensation Committee of Spectrum Pharmaceuticals. Dr. Vacirca is the co-founder and president of the National Translational Research group and holds a position for Caris Life Sciences as a Scientific Advisory Board Member. Additionally, he serves as a medical board advisor for Flatiron Health, located in New York City.
Dr. Vacirca has received numerous awards and accolades for his efforts in providing outstanding patient care including Humanitarian of the Year by the American Red Cross, the Theodore Roosevelt Award for outstanding dedication to patient care, and being named in Newsday’s Top Doctors. Additionally, he was honored for his role in enabling I-IAAC staff to bring state of the art HIV testing to New York.
